What this is
- This study evaluates mid-term outcomes after conversion procedures following laparoscopic sleeve gastrectomy (SG).
- It focuses on weight loss, resolution of medical issues, and reoperation rates in patients converted from SG.
- The analysis includes data from a single center with a follow-up of at least 2 years.
Essence
- Conversion from laparoscopic sleeve gastrectomy to biliopancreatic diversion with duodenal switch (BPD/DS) results in greater weight loss compared to other procedures. Conversion to Roux-en-Y gastric bypass (RYGB) effectively resolves () symptoms.
Key takeaways
- Conversion procedures were performed in 15.3% of patients after SG, primarily due to and ().
- BPD/DS achieved the highest total weight loss (%TWL) at 36.6%, followed by long biliopancreatic limb Roux-en-Y gastric bypass at 32.9%. Re-sleeve gastrectomy had the lowest %TWL at 20.0%.
- RYGB led to a 79.5% resolution of symptoms, indicating its effectiveness for patients experiencing this complication after SG.
Caveats
- The study's retrospective design limits the ability to draw definitive conclusions about causation. Additionally, the sample size for some procedures was small, which may affect the reliability of the outcomes.
- Follow-up duration varied, and while the average was over 5 years, individual patient follow-up times may differ, potentially influencing results.
Definitions
- Insufficient Weight Loss (IWL): Failure to achieve expected weight loss after bariatric surgery, often leading to the need for further interventions.
- Gastroesophageal Reflux Disease (GERD): A chronic digestive condition where stomach acid or bile irritates the food pipe lining, leading to symptoms like heartburn.
Simplified
Introduction
According to the 2018 International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Survey, sleeve gastrectomy (SG) has become the most commonly performed bariatric procedure worldwide with 55.4% [1]. Primary SG is a widely accepted stand-alone procedure regarding weight loss (WL) with a good safety profile and a high rate of resolution of associated medical problems [2, 3]. However, different studies examining mid- to long-term results of SG have found potential associated complications. The most frequent are insufficient weight loss (IWL) or weight regain (WR), with studies showing WR rates of 27.8 to 51.4% after 7 years of follow-up, and gastroesophageal reflux disease (GERD), with an incidence of de novo GERD symptoms ranging from 23.0 to 42.9% within a 10-year follow-up period and an increase of postoperative GERD symptoms in 19.0% of patients [4–7]. Commonly found non-GERD-related persistent associated medical problems are arterial hypertension (HTN) and obstructive sleep apnea (20.2%) followed by type II diabetes (T2D) (12.8%) [8]. Multiple reasons have been attributed to IWL: technical factors such as enlarged postoperative sleeve volume due to insufficient resection as well as changes in dietary habits and physical activity [9, 10]. Further, postoperative sleeve dilatation may occur and is thought to promote WR, thus leading to the development of the banded SG [11, 12]. In regard to GERD, various underlying mechanisms have been described: lack of gastric compliance and emptying, a high-pressure setting after SG, an increased esophagogastric insertion angle, and a small gastric capacity [13–15]. Amongst others, these complications may necessitate a second operation. Conversion rates after SG range from 6.1 to 22.6% increasing with follow-up duration [16, 17]. The predominant causes found, were GERD (2.9 to 65.2%) and IWL/WR (11.8 to 55.7%) followed by stricture (14.0%), kinking of the sleeve (11.0%), or fistula (1.9%) [2, 4, 16–19]. The average time to conversion varied from 31 months after short- to 5.6 years after long-time follow-up [8, 18].
The objective of this study was to evaluate indications for conversion, weight loss outcomes, and postoperative complications as well as the evolution of associated medical problems and required further operations for patients who underwent a conversion after SG at a single institution.
Methods
Design, Patients, and Preoperative Workup
For this single-center retrospective study, data was obtained from a prospective database on patients undergoing bariatric surgery. Included were patients with a minimal follow-up of 24 months after conversion from SG. The study was approved by the local ethics committee. Reasons for conversion were: GERD in spite of medication and IWL with no fixed weight loss limit applied, including WR with relapse of associated medical problems and a combination of GERD + IWL as well as stenosis/kinking of the sleeve. In patients with IWL, we predominantly performed a biliopancreatic diversion with duodenal switch (BPD/DS) or long biliopancreatic limb Roux-en-Y gastric bypass (long BPL RYGB) if they additionally suffered from GERD, whereas if GERD was the main problem, a short biliopancreatic limb Roux-en-Y gastric bypass (short BPL RYGB) was chosen. Re-sleeve gastrectomy (RSG) was only considered when sleeve dilatation was confirmed. Prior to conversion, all patients were discussed by an interdisciplinary team of endocrinologists, nutritionists, psychiatrists, and bariatric surgeons and had a routine medical check-up. Additionally, an upper gastrointestinal series and endoscopy were performed in all patients to detect hiatal hernias and reflux esophagitis, in which case a hiatal hernia repair was performed during the conversion. Furthermore, an abdominal sonography was carried out in patients with intact gallbladder, and a concomitant cholecystectomy was performed in case of gallstones to prevent the risk of common bile duct stones (CBDS) and cholecystitis after a RYGB procedure and routinely during BPD/DS surgery.
Surgical Technique
During the study period, four types of conversion were performed at our institution: SG to either short BPL RYGB, BPD/DS, long BPL RYGB, or RSG. The short BPL RYGB consistent of an antecolic alimentary limb of 150 cm with a linear gastro-jejunostomy and a biliopancreatic limb of 50 cm, whereas the long BPL RYGB had a biliopancreatic limb of 150 cm and an alimentary limb of 100 cm. The jejuno-jejunal mesenteric defect was closed routinely. The BPD/DS was created by a 150 cm alimentary limb with a duodeno-ileostomy and a common channel of 100 cm. The RSG was calibrated over a 32 to 35 French bougie, and the proximal staple line was routinely reinforced with an absorbable running suture.
Postoperative Outcomes
All patients underwent regular follow-up visits where vital sings, weight change, medical problems, current medication, and laboratory values regarding micronutrients were assessed. Weight outcomes for each group were recorded as mean initial weight and body mass index (BMI), and changes were noted as percentage of total weight loss (%TWL), excess weight loss (%EWL), and as ΔBMI. Associated medical problems evaluated pre- and postoperatively were reported in accordance to the executive summary of American Society for Metabolic and Bariatric Surgery (ASMBS) outcome reporting standards [20].
Statistical Analysis
The statistical analysis was conducted using GraphPad Prism version 9 and StataMP 17. Continuous and categorical data were described using mean and standard deviation as well as counts and percentages, respectively. Data comparison was performed applying either one-way ANOVA or Kruskal–Wallis test where applicable or Fisher’s exact test. A statistically significant value for p was considered to be < 0.05.
Results
Patients
| Study cohort | Short BPL RYGB | BPD/DS | Long BPL RYGB | RSG | valuep | |
|---|---|---|---|---|---|---|
| = 71n | = 28n | = 19n | = 17n | = 7n | ||
| Sex | ||||||
| Female –(%)n | 53 (74.6) | 22 (78.6) | 17 (89.5) | 10 (58.8) | 4 (57.1) | 0.108 |
| Age (year) – mean (SD) | 51.9 (10.1) | 53.2 (9.1) | 47.5 (9.1) | 56.1 (11.2) | 48.1 (10.2) | 0.043 |
| Initial weight (kg) – mean (SD) | 128.9 (26.2) | 114.4 (12.7) | 140.2 (29.7) | 137.5 (29.7) | 135.3 (25.6) | 0.003 |
| Initial BMI (kg/m) – mean (SD)2 | 46.2 (7.8) | 42.4 (4.3) | 51.5 (8.8) | 47.2 (8.8) | 44.7 (5.4) | 0.003 |
| Lowest weight (kg) – mean (SD) | 93.1 (21.5) | 80.7 (15.4) | 105.0 (17.2) | 97.9 (25.7) | 98.3 (20.5) | 0.001 |
| Lowest BMI (kg/m) – mean (SD)2 | 33.4 (6.8) | 29.7 (4.5) | 38.7 (5.1) | 33.7 (8.3) | 32.7 (6.0) | < 0.001 |
| Pre-revisional weight (kg) – mean (SD) | 106.2 (24.2) | 90.8 (16.4) | 118.5 (17.3) | 112.5 (26.3) | 119.0 (31.5) | 0.002 |
| Pre-revisional BMI (kg/m) – mean (SD)2 | 38.0 (7.5) | 33.6 (5.2) | 43.7 (5.6) | 38.6 (7.8) | 39.1 (8.1) | < 0.001 |
| GERD –(%)n | 47 (66.2) | 25 (89.3) | 4 (21.1) | 14 (82.4) | 4 (57.1) | < 0.001 |
| Hypertension –(%)n | 34 (47.9) | 11 (39.3) | 12 (63.2) | 7 (41.2) | 4 (57.1) | 0.394 |
| Diabetes –(%)n | 15 (21.2) | 5 (17.8) | 6 (31.6) | 4 (23.5) | 0 | 0.372 |
| Reasons for conversion | ||||||
| GERD –(%)n | 24 (33.8) | 17 (60.7) | 0 | 5 (29.4) | 2 (28.6) | < 0.001 |
| IWL –(%)n | 23 (32.4) | 3 (10.7) | 15 (79.0) | 2 (11.8) | 3 (42.8) | < 0.001 |
| IWL + GERD –(%)n | 22 (31.0) | 6 (21.4) | 4 (21.0) | 10 (58.8) | 2 (28.6) | 0.047 |
| Kinking/stenosis –(%)n | 2 (2.8) | 2 (7.2) | 0 | 0 | 0 | 0.594 |
Conversion
Patients underwent conversion to either short BPL RYGB (n = 28, 39.4%), BPD/DS (n = 19, 26.8%), long BPL RYGB (n = 17, 23.9%), or RSG (n = 7, 9.9%). Sixty-eight out of 71 (95.8%) procedures were performed laparoscopically. One patient had a planned open approach, and two patients had to be converted from laparoscopic to open due to adhesions from multiple previous abdominal operations. Concomitant procedures were performed depending on preoperative findings. Twenty-six out of 71 patients (36.6%) had a concomitant cholecystectomy, 35/71 (49.3%) had a hiatal hernia repair, and 5/71 (7.0%) received an abdominal hernia repair. Indications for conversion were GERD (24/71, 33.8%), IWL (23/71, 32.4%), a combination of both (22/71, 31.0%), or kinking/stenosis of the sleeve (2/71, 2.8%) (Table 1).
Weight Loss During Study Period
Additional weight loss after conversion at 1, 2, and 3 years for patients with IWL and IWL + GERD as indication for conversion. Short BPL RYGB = short biliopancreatic limb Roux-en-Y gastric bypass; BPD/DS = biliopancreatic diversion with duodenal switch; long BPL RYGB = long biliopancreatic limb Roux-en-Y gastric bypass; RSG = re-sleeve gastrectomy; % EWL = percentage of excess weight loss
Comparison of additional weight loss after conversion at 1, 2, and 3 years for patients with IWL and IWL + GERD as indication for conversion. Short BPL RYGB = short biliopancreatic limb Roux-en-Y gastric bypass; BPD/DS = biliopancreatic diversion with duodenal switch; long BPL RYGB = long biliopancreatic limb Roux-en-Y gastric bypass; RSG = re-sleeve gastrectomy; %TWL = percentage total weight loss; %EWL = percentage excess weight loss; *≤ 0.05; **≤ 0.01 p p
| Short BPL RYGB | BPD/DS | Long BPL RYGB | RSG | valuep | |
|---|---|---|---|---|---|
| = 9n | = 19n | = 12n | = 5n | ||
| Total | |||||
| % TWL – mean (SD) | 28.0 (9.6) | 36.6 (10.0) | 32.9 (7.0) | 20.0 (7.3) | 0.004 |
| % EWL – mean (SD) | 60.4 (17.6) | 73.5 (16.1) | 72.0 (8.8) | 43.5 (15.7) | 0.001 |
| Weight loss/BMI changes at 1 year | |||||
| Additional % TWL – mean (SD) | 17.2 (7.0) | 23.9 (6.1) | 18.5 (6.8) | 13.4 (14.4) | 0.027 |
| Additional % EWL – mean (SD) | 54.2 (23.0) | 58.5 (19.7) | 53.9 (13.6) | 33.8 (34.7) | 0.156 |
| Additional Δ BMI – mean (SD) | 6.5 (2.8) | 10.5 (2.9) | 7.8 (4.3) | 6.1 (7.1) | 0.039 |
| Weight loss/BMI changes at 2 years | |||||
| Additional % TWL – mean (SD) | 15.0 (11.0) | 27.4 (8.2) | 21.0 (9.8) | 11.6 (15.3) | 0.006 |
| Additional % EWL – mean (SD) | 43.3 (35.8) | 65.7 (19.3) | 58.7 (16.9) | 27.8 (35.0) | 0.016 |
| Additional Δ BMI – mean (SD) | 5.8 (4.3) | 12.2 (4.5) | 9.0 (6.0) | 5.5 (7.8) | 0.016 |
| Weight loss/BMI changes at 3 years | |||||
| Additional % TWL – mean (SD) | 13.8 (8.5) | 27.3 (9.0) | 20.8 (6.7) | 8.7 (12.3) | 0.001 |
| Additional % EWL – mean (SD) | 40.5 (24.8) | 65.5 (20.0) | 60.4 (9.1) | 24.4 (33.4) | 0.005 |
| Additional Δ BMI – mean (SD) | 5.3 (3.4) | 12.2 (5.0) | 8.3 (3.5) | 3.5 (5.1) | 0.001 |
Postoperative Outcomes
Regarding mid-term complications such as marginal ulcer, stricture, leakage and dumping, there was no significant difference between groups (Table 3). During the study period, 12/71 patients (16.9%) required a further operation after conversion for internal herniation, IWL, and CBDS. Two patients in the BPD/DS group suffered from chronic diarrhea, which did not respond to medical treatment, and malnutrition and required a small intestine interposition to reduce malabsorption. Gastric bypass procedures lead to a resolution of GERD in 79.5%. There was no statistically significant difference regarding the persistence of associated medical problems (i.e., GERD, HTN, and T2D) between procedures.
| Short BPL RYGB | BPD/DS | Long BPL RYGB | RSG | valuep | |
|---|---|---|---|---|---|
| = 28n | = 19n | = 17n | = 7n | ||
| 30-day complications –(%)n | |||||
| Clavien Dindo IVa | 1 (3.6) | 0 | 0 | 0 | 1 |
| Clavien Dindo IIIb | 1 (3.6) | 0 | 1 (5.9) | 0 | 0.786 |
| Clavien Dindo IIIa | 2 (7.1) | 0 | 0 | 0 | 0.594 |
| Clavien Dindo II | 5 (17.9) | 0 | 1 (5.9) | 0 | 0.163 |
| Clavien Dindo I | 0 | 0 | 2 (11.8) | 0 | 0.165 |
| Mid-term complications –(%)n | |||||
| Marginal ulcer | 2 (7.1) | 0 | 1 (5.9) | 0 | 0.716 |
| Stricture | 1 (3.6) | 1 (5.3) | 0 | 0 | 1 |
| Leakage | 1 (3.6) | 0 | 0 | 0 | 1 |
| Dumping | 8 (28.6) | 1 (5.3) | 2 (11.8) | 0 | 0.13 |
| Reoperation | 8 (28.6) | 3 (15.8) | 1 (5.9) | 0 | 0.173 |
| Internal hernia | 4 (14.3) | 1 (5.3) | 1 (5.9) | 0.66 | |
| Reversal | 0 | 2 (10.5) | 0 | 0 | 0.233 |
| IWL | 3 (10.7) | 0 | 0 | 0 | 0.33 |
| CBDS | 1 (3.6) | 0 | 0 | 0 | 1 |
| Persistence of AMP –(%)n | |||||
| GERD | 4 (14.3) | 5 (26.3) | 4 (23.5) | 2 (28.6) | 0.665 |
| Hypertension | 9 (32.1) | 9 (47.4) | 3 (17.7) | 4 (57.1) | 0.17 |
| Diabetes | 7 (25.0) | 1 (5.3) | 1 (5.9) | 0 | 0.169 |
Discussion
The main findings of this study include a conversion rate of 15.3% after an average of 5.2 years after SG for mainly GERD (33.8%) and IWL (32.4%) or a combination of both factors (31.0%). Further, we found that the greatest additional weight loss was reached after a conversion with an additional hypo-absorptive component such as BPD/DS or long BPL RYGB. Conversion to a short BPL RYGB led to an initial weight loss which was not sustainable and RSG only led to a minimal additional EWL. After conversion to a RYGB procedure, the resolution of GERD symptoms was 79.5%. Severe short-term complications happened in 7% of patients with no statistical difference between groups.
The above-described conversion rate corresponds to current literature with an overall revision rate of 10.4% increasing to 22.6% if only patients with a follow-up ≥ 10 years are considered [17]. Felsenreich et al. even noted a conversion rate of 49.1% from SG to RYGB with a follow-up of 15 years [22]. However, a significant number of patients show a satisfying outcome after SG as a stand-alone procedure with a long-term percentage excess body mass index loss between 51.0 and 54.0% and a significant improvement of related associated medical problems. Nevertheless, the frequently observed problems of IWL and de novo GERD led to a reoperation rate of 19.2% [23]. It is therefore crucial to inform all patients prior to a SG of the possible complications such as IWL/WR or GERD. It is essential to identify those patients and evaluate conversion before a clinically relevant relapse of associated medical problems occurs. There are various options for conversion of the SG depending on the indication for conversion. In the event of IWL and confirmed sleeve dilatation, a meta-analysis including 196 patients undergoing RSG described a pooled mean EWL of 61.5% after 1 year [24]. However, Cheung et al. found a decline in EWL from 68.0% at 1 year to 44.0% at 2 years after RSG corresponding to our own results of a total EWL of 43.5% [25]. The additional EWL was even lower with 24.4% after 3 years. Therefore, RSG does not seem to be the ideal option for conversion in case of IWL. After a conversion to RYGB, Abdemur et al. found 76.5% total EWL and 30.9% additional EWL with a mixed indication for conversion including GERD [26]. In a subgroup analysis of patients with IWL, D’Urso et al. reported 50.8% total EWL at 1 year decreasing to 45.3% at 3 and 33.8% at 5 years[18]. In our cohort, we similarly saw that a short BPL RYGB led to an initial additional weight loss, which was, however, not sustainable. Therefore, patients with IWL do not seem to profit from such a conversion and seem to need an additional hypo-absorptive component in their bariatric conversion. Revisional procedures with different biliopancretic limb (BPL) lengths have been investigated, and long BPL type procedures were shown to have a significantly higher additional EWL lasting for more than 3 years, while in short BPL type procedures, such as proximal Roux-en-Y gastric bypass, the significance only persisted for 2 years [27]. Andalib et al. and Shimon et al. reported higher TWL after BPD/DS (14.0%; 26.3%) compared to RYGB (10.1%; 18.8%) [8, 28]. Correspondingly, we saw the highest additional weight loss after BPD/DS and long BPL RYGB. However, two patients in the BPD/DS group required a reversal due to chronic diarrhea and malnutrition. In literature, similar results can be found with a small number of patients suffering from severe malnutrition and steatorrhea after BPD/DS and long BPL RYGB [8, 27, 28]. Therefore, a careful patient selection and stringent postoperative follow-up regime is mandatory in case of conversion to BPD/DS to avoid severe side effects.
For GERD as an indication for conversion, RYGB is an effective procedure leading to a remission in 74.0 to 91.3% of patients [29, 30].
In regard to resolution of associated medical problems, BPD/DS shows satisfying results with remission rates of T2D of up to 94.0% and up to 87.5% for HTN [31, 32]. For RYGB, remission rates for T2D of 57.0% and HTN of 44.4% have been found [28, 33]. In our cohort, we have noted a relatively low remission rate of T2D after RYGB of 11.2%, whereas after BPD/DS, it was at 83.3%. Regarding HTN, remission occurred in 33.3% of patients after RYGB and in 25.0% of patients after BPD/DS. However, the incidence of preoperative associated medical problems was relatively low, and the interpretation of the analysis’ results for the four subgroups must, therefore, be done carefully.
Thirty-day complications after conversion to RYGB have been noted between 3.3 and 16.4% [18, 29]. The accumulation of complications after RYGB procedures compared to the other groups in this cohort is most likely a coincidence due to the small sample size, since they are the predominantly performed procedures in our clinic. Andalib et al. compared conversion to RSG, RYGB, and BPD/DS and found a 90-day complication rate of 7.4% [8]. We have seen similar results with 7.0% short-term complications without any statistically significant difference between procedures. Thus, the safety aspect of conversional surgery after SG should not affect the choice of the suitable procedure, since there is no statistical significance amongst them.
Study limitations include the retrospective analysis of prospectively collected data and the small sample size with four different revisional procedures as subgroups. At our institution, we have more than 25 years of experience with BPD/DS and 19 years with SG as a primary stand-alone procedure; however, SG accounts for less than 15.0% of all primary procedures. Yet, the long follow-up time and high follow-up rate of this series support our data.
Conclusion
Conversion to BPD/DS leads to a significantly higher weight loss than RSG and short BPL RYGB. However, a close follow-up is needed to detect possible nutritional problems. Long BPL RYGB also led to relevant additional weight loss without any severe mid-term nutritional complications and is a valid alternative to BPD/DS. RYGB procedures prompted a good symptom control in patients suffering from GERD.